Browse Gemcitabine topic

Dosage and administration subtopic

Articles

1-13 out of 13 article(s)

Title	Author	Type	Date	Words
NCCAM/NCI phase 1 study of mistletoe extract and Gemcitabine in patients with advanced solid tumors.	Mansky, P.J.; Wallerstedt, D.B.; Sannes, T.; Stagl, J.; Johnson, L.L.; Blackman, M.R.; Grem, J.L.; S	Report	Oct 15, 2011	446
Options and limitations of ductal pancreatic cancer treatment.	Seufferlein, Thomas	Report	Oct 15, 2011	406
APP Pharmaceuticals Announces Approval and Launch of Gemcitabine HCI for Injection, USP in 2 Gram Dosage Form.			May 19, 2011	870
APP Pharmaceuticals Announces Agreement with Teva Pharmaceuticals to Manufacture and Market Gemcitabine HCI for Injection.			Jan 26, 2011	1021
Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group.	Guillen, Ponce; Carrato, Alfredo	Clinical report	Oct 1, 2009	1431
In patients with unresectable (inoperable) pancreatic cancer, the combination of gemcitabine and a novel cationic liposomal formulation of paclitaxel called EndoTAG-1 substantially prolongs survival compared to gemcitabine therapy alone, according to a study presented last week.		Brief article	Jun 29, 2009	271
A Phase I study of full-dose gemcitabine and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer.	Carrato, Alfredo; Guillen-Ponce, Carmen		Dec 1, 2008	866
Gemcitabine and cisplatin in patients with locally advanced, recurrent, or metastatic head and neck cancer: results of a Phase II trial.	Kyasa, Mouhammed J.; Breau, Randall L.; Hanna, Ehab; Suen, James; Maddox, Anne-Marie		Mar 1, 2008	2464
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.	Carrato, Alfredo; Guillen-Ponce, Carmen	Clinical report	Dec 1, 2007	1188
Bevacizumab disappoints in pancreatic cancer.			Apr 1, 2007	437
Avantogen Oncology Inc. Announces Preliminary Results of a Dose Ranging Study of RP101 in Combination With Gemcitabine Chemotherapy in Patients With Advanced Pancreatic Cancer.			Aug 17, 2006	685
Gemcitabine-radiation Tx thwarts pancreatic Ca.	Wendling, Patrice		Aug 1, 2005	572
Chemo boosts pancreatic cancer-free survival.	MacNeil, Jane Salodof		Aug 1, 2005	1073